Janus faces of microglia in multiple sclerosis

Area of Science:

• Neuroimmunology
• Neurology
• Cellular Biology

Background:

• Multiple sclerosis (MS) is a leading cause of neurological disability in young adults.
• MS pathology involves inflammation, demyelination, and axonal loss in the central nervous system.
• Microglia are implicated in MS pathogenesis due to their presence in active lesions and role in T cell differentiation.

Purpose of the Study:

• To review the critical functions of microglia-associated molecules in multiple sclerosis.
• To elucidate the dual role of microglia in initiating and resolving inflammation in MS.
• To identify therapeutic targets for manipulating microglial function in MS.

Main Methods:

• Literature review of studies on microglia and MS.
• Analysis of the roles of specific microglia-associated molecules (CD40, B7-1, B7-2, IFN-γ, TNF-α, chemokines, prostanoids, NO).
• Synthesis of current understanding of microglial involvement in MS pathogenesis.

Main Results:

• Microglia contribute to T cell-mediated inflammation and tissue damage in MS.
• Microglia also possess anti-inflammatory and protective functions.
• Key molecules like CD40, B7-1/2, IFN-γ, and TNF-α modulate microglial activity and disease progression.

Conclusions:

• Clarifying the precise functions of microglia and their associated molecules is essential for MS therapeutic development.
• Targeting specific microglial pathways may offer novel treatment strategies for MS.
• Further research is needed to fully harness microglia's therapeutic potential in managing MS.